Neoadjuvant Sorafenib Therapy Prior to Laser Ablation for Hepatocellular Carcinoma
Status:
Completed
Trial end date:
2016-09-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether neoadiuvant therapy with sorafenib
increases the efficacy of thermal ablation in inducing the necrosis of hepatocellular
carcinoma.